Record High GLP-1 Use; Intense Interval Exercise; Endometriosis and Androgens

(MedPage Today) -- Americans' use of GLP-1 injectables for weight loss reached a record high, nearly quadrupling since 2024, according to a national Gallup poll.
For patients with type 2 diabetes and peripheral artery disease, GLP-1 receptor agonists...